Fan Chen has joined genomic diagnostic startup Medomics (see article in this issue) as chief technical officer. Most recently, he was a principal scientist at Focus Diagnostics, which is part of Quest Diagnostics. Prior to that, he was director of R&D at Clingenix, where he focused on diagnostic marker discovery and development. He also held scientific and management positions at MJ Research, Iris Biotechnologies, and Warner Lambert Pharmaceuticals. Chen holds a BS in medicine from Beijing University and a PhD in medical sciences from Nagoya University in Japan.
Antonius Schuh and Michael McNulty have joined the board of directors of Transgenomic.
Schuh is the founding chairman and CEO of Sorrento Therapeutics, a biotechnology company. Prior to that, he was the founding CEO and director of AviaraDx, a molecular diagnostics laboratory company, and before that, he was CEO of Arcturus Bioscience and Sequenom.
McNulty is general manager of diagnostics at Agilent Technologies. Prior to that, he was vice president of laboratory operations and chief compliance officer of Berkeley Heartlabs.